March 29, 2016
Gaithersburg’s MaxCyte lists on the London Stock Exchange, plans to begin immunotherapy drug development – Washington Business Journal
Gaithersburg cell modification technology firm MaxCyte Inc. is expected to go public on the London…
March 29, 2016
Mach37 Cybersecurity Accelerator: Spring 2016 Cohort
The cybersecurity industry is predicted to double by 2020 and the DC metro area is…
March 29, 2016
10 Most Common Questions from Physician Entrepreneurs | Arlen Meyers, MD, MBA – LinkedIn
Physician entrepreneurs or wannapreneurs ask a lot of questions about the processes of biomedical and…
March 25, 2016
Rexahn Pharma (RNN) Announces Additional Data on Supinoxin for Treating Triple Negative Breast Cancer at TAT
Rexahn Pharmaceuticals, Inc. (NYSE MKT: RNN) announced today that additional data supporting the Company’s novel,…
